川宁生物：预计未来毛利率处于回升状态

Core Viewpoint - Chuaning Bio announced a gradual decline in penicillin product prices and that the price of 6-APA is currently at historical lows, indicating a challenging pricing environment for the company [2] Pricing Summary - The price of penicillin products is gradually decreasing, while 6-APA prices are fluctuating at historical low levels [2] Cost Summary - The cost in the first three quarters showed little fluctuation compared to the first half of the year, with the primary impact on gross profit margin stemming from price volatility [2] Future Outlook - With the arrival of the peak season in the fourth quarter and an increase in downstream market demand, the company expects a recovery in gross margin [2]